Clinical Trial Update: Metronomic Capecitabine in Stage III Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metronomic dosing of capecitabine for stage III gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 3 | Status: RECRUITING